[Sponsored] A new eBook, sponsored by PurpleLab, examines how a significant number of patients with non-small cell lung cancer miss out on optimal care due to gaps in biomarker testing, socioeconomic barriers, incomplete patient journey data, and what can be done to change that. The post How Real-World Data Is Reshaping the NSCLC Patient Journey…
LISTEN: Can’t afford health insurance this year? Don’t be afraid to talk to your doctor about money and the cost of care. On WAMU’s “Health Hub” on March 4, KFF Health News correspondent Sam Whitehead shared tips for people seeking affordable options without skipping care. Health insurance could be out of reach for many Americans…
Pharmacies and wholesalers claimed Takeda Pharmaceutical delayed generic competition from entering the market, forcing them to overpay for a gastrointestinal drug. Takeda said the trial had “evidentiary and legal errors,” and the company will appeal the verdict. The post Takeda Vows Appeal of $885M Jury Verdict in ‘Pay-for-Delay’ Antitrust Case appeared first on MedCity News.
The policy conversation needs to shift from just deprescribing alone to building the clinical infrastructure that delivers consistent, high-quality behavioral health care. The post Better Prescribing, Not Less Prescribing, Is What Behavioral Health Needs appeared first on MedCity News.
The United States has made almost no progress in closing racial health disparities despite promises, research shows. The government, some critics argue, is often the underlying culprit. KFF Health News undertook a yearlong examination of how government decisions undermine Black health — reviewing court and inspection records and government reports, and interviewing dozens of academic…
After years working with CHCs, John Torontow, M.D., M.Ph., sees value-based care as more than a payment strategy. He argues it is an opportunity to make the health centers’ often-invisible work measurable, recognized and financially sustainable.
This resource examines U.S. global health funding awards going to U.S.-based implementers in FY2024, by state and congressional district
Numerous advocacy organizations are sounding the alarm over a recent HHS notice that restricts access to federal benefits for undocumented immigrants, as well as for those lawfully present. The post Why HHS’ Notice On Federal Public Benefits Harms Both Lawfully Present and Undocumented Immigrants appeared first on MedCity News.
Triumphant music plays as cancer patients go camping, do some gardening, and watch fireworks in ads for Opdivo+Yervoy, a combination of immunotherapies to treat metastatic melanoma and lung cancer. Ads for Skyrizi, a medicine to treat plaque psoriasis and other illnesses, show patients snorkeling and riding bikes — flashing their rash-free elbows. People with Type…
The billionaire Mark Cuban whose Cost Plus Drugs company has been shaking up the world of prescription drug coverage minces no words when it comes to the role of employers in bringing down healthcare costs. But some employers believe he is wrong. The post Is Mark Cuban Wrong About Employers, PBMs and Drug Prices? appeared…